Tokyo court rejects Shire claim against Roche haemophilia drug

Chugai, which is 60 percent Roche-owned and which developed Hemlibra, said it expected no change to its financial prospects due to the ruling. “Tokyo District Court rendered a decision in favour of Chugai’s claim,” Chugai said on its website. “(Shire’s …
( read original story …)


Related Post

Nikkei rises to 5-week high on Powell’s comments
views 36
Japan's Nikkei rose to near five-week highs on Mon...
Russia Interested in Developing Hi-Tech Industry C...
views 69
and it is rather modest — some $2 billion by Japan...
Bank of Japan Sticks With Holding Pattern
views 114
TOKYO—The Bank of Japan left its aggressive easing...
Japan’s Rakuten to acquire Asahi Fire for 45...
views 148
TOKYO (Reuters) - Japanese e-commerce company Raku...
Takefusa Kubo, previously on the books at the Camp...
views 273
as he came on as a substitute in the Levain Cup ga...
Japan's Feb exports jump 11.3 per cent
views 262
Japan's exports to China rose sharply in February,...
Osaka: Man shot by officer in Miyakojima Ward had ...
views 128
OSAKA (TR) – Investigative sources revealed on Tue...
Tokyo Olympics: Costs hit almost $25 billion _ may...
views 10
TOKYO — The price tag keeps soaring for the 2020 T...
Japan tries to solve the problem of employees lite...
views 235
At Dentsu, a 24-year-old woman killed herself afte...
Nikkei stays in a narrow range, on track for weekl...
views 225
Yen moves off this week's highs, underpinning Japa...